The present disclosure relates generally to syringe systems comprising barrels including lubricated portions and non-lubricated portions. More specifically, in some embodiments, the present disclosure relates to barrels including non-lubricated portions configured to be loaded with injectable materials and methods of lubricating portions of the barrels. This disclosure also relates to various embodiments of plunger members, including plunger members having plunger tips configured to couple with a seal member. Related methods are also disclosed.
The embodiments disclosed herein will become more fully apparent from the following description and appended claims, taken in conjunction with the accompanying drawings. While various aspects of the embodiments are presented in drawings, the drawings depict only typical embodiments, which will be described with additional specificity and detail through use of the accompanying drawings in which:
The various embodiments disclosed herein generally relate to syringe systems comprising barrels including lubricated portions and non-lubricated portions. In some embodiments, the non-lubricated portions are configured to be loaded with injectable materials. In certain embodiments, the injectable materials may comprise polyvinyl alcohol (PVA). In various embodiments, the injectable materials may comprise a substance including gelatin foam (e.g., GELFOAM®). Also disclosed herein are methods of lubricating portions of barrels of syringe systems.
Embodiments may be understood by reference to the drawings, wherein like parts are designated by like numerals throughout. It will be readily understood that the components of the present disclosure, as generally described and illustrated in the drawings herein, could be arranged and designed in a wide variety of different configurations. Thus, the following more detailed description of the embodiments of the apparatus is not intended to limit the scope of the disclosure, but is merely representative of possible embodiments of the disclosure. In some cases, well-known structures, materials, or operations are not shown or described in detail. While the various aspects of the embodiments are presented in drawings, the drawings are not necessarily drawn to scale unless specifically indicated.
The term “silicone” refers to polymers that include repeating units of siloxane (e.g., poly-siloxane ((R2SiO)n)). As used herein, the terms silicone and poly-siloxane may be used interchangeably.
The term “shelf stable” refers to syringe systems, wherein any components of the syringe system, the injection material, and/or an interaction between the injection material and the syringe system (i.e., an interaction in a pre-loaded syringe system) are such that after a given timeframe (e.g., six months, one year, two years, three years, etc.) the syringe system and the injection material are still suitable for their intended purpose. For example, when the injection material comprises an embolic agent (e.g., a microparticle or a microsphere), agglomeration of the embolic agent may render the pre-loaded syringe system unsuitable for its intended purpose. For example, agglomeration of more than about 10% of the embolic agent may render the pre-loaded syringe unsuitable for its intended purpose. Likewise, adhesion of the injection material to one or more components of the syringe system (e.g., a barrel) may render the pre-loaded syringe unsuitable for its intended purpose.
The term “sterilization compatible” refers to components or materials configured to be sterilized without rendering the components or materials unsuitable for their intended purpose. If a component or material is configured for sterilization by at least one method of sterilization without being rendered unsuitable for its intended purpose, then the material is “sterilization compatible.” For example, a polymeric barrel may deform when autoclaved at temperatures sufficient to sterilize the barrel, rendering the barrel unsuitable for maintaining a seal with a seal member of a plunger. However, if the same polymeric barrel may be sterilized by another sterilization technique (e.g., by irradiation) and maintain suitability for its intended purpose, then the polymeric material is “sterilization compatible.”
The term “irradiation compatible” refers to components or materials configured to be sterilized by irradiation without rendering the components or materials unsuitable for their intended purpose. For example, a plunger or an interior surface of a barrel may comprise a material (e.g., a lubricant) that upon irradiation changes in physical properties such that the syringe is unsuitable for its intended purpose. For example, irradiation may alter certain materials such that a syringe using those materials would have an unacceptably high initial peak force required to start movement of a plunger. Or, in another example, irradiation may alter certain materials such that a syringe using those materials would have an unacceptably non-uniform force required for travel of the plunger over the length of the barrel or an unacceptably high force required for travel of the plunger over the length of the barrel.
As illustrated, the barrel 110 can comprise a proximal or lubricated portion 112 and a distal or non-lubricated portion 122, wherein the non-lubricated portion 122 may be disposed distal of the lubricated portion 112. In some embodiments, at least a portion of an interior surface of a first wall 111 of the barrel 110 disposed in the lubricated portion 112 may be at least partially coated with a lubricant or lubricant coating 114. In contrast to the lubricated portion 112, at least a portion of the interior surface of the first wall 111 and an interior surface of a second wall 121 of the barrel 110 disposed in the non-lubricated portion 122 may lack a lubricant or lubricant coating. The lubricant 114 may aid in the displacement of the plunger member 130 within at least a portion of the barrel 110 of the syringe system 100 (i.e., the lubricated portion 112). For example, the plunger member 130 may be more easily displaced within the lubricated portion 112 of the barrel 110 than within the non-lubricated portion 122 of the barrel 110.
As illustrated, at least a portion of the barrel 110 (i.e., the non-lubricated portion 122) may be configured to receive or be loaded with an injectable material 102. For example, the injectable material 102 may be disposed within the non-lubricated portion 122. In some embodiments, the injectable material 102 may not be compatible with the lubricant 114. For example, the injectable material 102 may be at least partially formed from a material that may become contaminated, or become unsuitable for its intended purpose, upon contact with the lubricant 114. As such, in certain embodiments, the syringe system 100 may be configured such that the injectable material 102 may be disposed in the barrel 110 such that the lubricant 114 does not, or does not substantially, come into contact with the injectable material 102 during shipment, storage, and/or sterilization.
The syringe system 100 can comprise a pre-loaded syringe system. For example, as illustrated in
In various embodiments, the injectable material 102 may comprise PVA or be at least partially formed from PVA, while the lubricant 114 may comprise silicone or be at least partially formed from silicone. In various other embodiments, the injectable material 102 may comprise a substance including gelatin foam or be at least partially formed from a substance including gelatin foam. Disclosure of PVA herein may be analogously applied to other substances, for example, substances including gelatin foam. Materials comprising PVA or gelatin foam may become contaminated upon contact with or exposure to silicone. For example, PVA or gelatin foam may not be compatible with silicone. Accordingly, it may be desirable to provide a barrel 110 including both a lubricated portion 112 and a non-lubricated portion 122. The lubricated portion 112 may facilitate displacement or movement of the plunger member 130 within at least a portion of the barrel 110. Additionally, the non-lubricated portion 122 may be loaded with the injectable material 102 and provide a location or position within the syringe system 100 wherein the injectable material 102 may avoid or substantially avoid contact with or exposure to the lubricant 114 (e.g., until the injectable material 102 has been hydrated).
In certain embodiments, the injectable material 102 may be dry. In certain other embodiments, the injectable material 102 may be suspended in a liquid, such as, for example, a carrier liquid comprising saline. In some embodiments, the injectable material 102 may be dry during shipment and/or storage of the syringe system 100 or the barrel 110. In some other embodiments, the injectable material 102 may be suspended in a liquid or hydrated during shipment and/or storage of the syringe system 100 or the barrel 110.
In some embodiments, the injectable material 102 may be selected from at least one of embolic agents, polymeric microparticles, polymeric microspheres, etc. In some embodiments, the injectable material 102 may be an embolic agent comprising a microparticle and/or a microsphere. Examples of microparticles include, but are not limited to, PVA microparticles (e.g., BEARING™ non-spherical PVA microparticles) and/or gelatin foam microparticles (e.g., GELFOAM® microparticles). Examples of microspheres include, but are not limited to, trisacryl cross-linked with gelatin microspheres (e.g., EMBOSPHERE® microspheres), sodium acrylate vinyl alcohol copolymer microspheres (e.g., HEPASPHERE® microspheres), PVA-based hydrogels (e.g., DC BEAD® microspheres), and/or gelatin foam microspheres (e.g., GELFOAM® microspheres).
As described above, the injectable material 102 may comprise PVA or gelatin foam. In certain other embodiments, the injectable material 102 may comprise an embolic agent, wherein the embolic agent may comprise PVA or gelatin foam. An injection material or an embolic agent comprising PVA may include PVA monomers, such as PVA polymers and copolymers.
A distal flange 147 can be positioned distally of the proximal flange 146. A rotational locking detent 145 may be disposed on a distally facing surface of the distal flange 147. The locking detent 145 can include an angled face 148 and a substantially normal or perpendicular face 149. The angled face 148 may include an angle ranging between 30 degrees and about 60 degrees, and may include an angle of about 45 degrees relative to the distally facing surface. The perpendicular face 149 can include an angle of about 90 degrees relative to the distally facing surface. The locking detent 145 can be configured to mate with a feature of the plunger tip 150 as explained below. A plunger rod tip 144 can extend distally from the distal flange 147. In the illustrated embodiment, the plunger rod tip 144 may include an external thread. The external thread can be a single start thread having a pitch ranging between about 1 millimeters and 2.5 millimeters, and having a pitch of about 1.5 millimeters. In some embodiments, the external thread can be a single start thread having a pitch ranging between about 1.016 millimeters and about 2.032 millimeters, and having a pitch of about 1.5875 millimeters. The plunger rod tip 144 can allow rotational coupling of the plunger tip 150 to the plunger rod 140. In other embodiments, the plunger rod tip 144 may include any other suitable type of coupling member to facilitate coupling of the plunger rod 140 with the plunger tip 150. For example, the plunger rod tip 144 may include a snap fit, a press fit, a friction fit, a bayonet lock, etc.
The plunger tip 150 may include an internal thread 155 disposed within a bore 157 and configured to facilitate rotational coupling of the plunger tip 150 with the plunger rod 140. The internal thread can be a single start thread having a pitch ranging between about 1 millimeters and about 2.5 millimeters, and having a pitch of about 1.5 millimeters. In certain embodiments, the internal thread may be configured to threadingly engage with the external thread of the plunger rod tip 144 when the plunger rod 140 is coupled to the plunger tip 150. The single starts of the internal and external threads may be oriented such that the proximal flange 153 bottoms out or contacts the distal flange 147 when the slot 151 engages with the locking detent 145. Nubs 154 can extend distally from distally facing surfaces of the distal and/or proximal flanges 152, 153. The nubs 154 can be configured to engage with the seal member 170 to prevent rotation of the plunger tip 150 relative to the seal member 170.
Turning ahead in the drawings,
Turning specifically to
A plunger rod tip 444 can extend distally from the distal flange 446. In the illustrated embodiment, the plunger rod tip 444 may include an external thread. The external thread can be a single start thread having a pitch ranging between about 1 millimeters and 2.5 millimeters, and having a pitch of about 1.5 millimeters. The plunger rod tip 444 can allow rotational coupling of the plunger tip 450 to the plunger rod 440. In other embodiments, the plunger rod tip 444 may include any other suitable type of coupling member to facilitate coupling of the plunger rod 440 with the plunger tip 450. For example, the plunger rod tip 444 may include a snap fit, a press fit, a friction fit, a bayonet lock, etc. In some embodiments, the plunger rod tip 444 may include a recess 460 on a distal end thereof that is sized complementary to an inner rim 459 or protrusion in a bore 457 of the plunger tip 450 such that the inner rim 459 may fit at least partially within the recess 460 of the plunger rod tip 444. The inner rim 459 and the recess 460 may be configured to provide a friction lock or securement between the plunger tip 450 and the plunger rod 440. For example, the inner rim 459 may interference fit with the recess 460. This interaction of the interference fit may releasably lock the plunger rod 440 and the plunger tip 450, thereby preventing or inhibiting the plunger rod 440 and the plunger tip 450 from coming apart.
The plunger tip 450 may include an internal thread 455 disposed within a bore 457 and configured to facilitate rotational coupling of the plunger tip 450 with the plunger rod 440. The internal thread can be a single start thread having a pitch ranging between about 1 millimeters and about 2.5 millimeters, and having a pitch of about 1.5 millimeters. In certain embodiments, the internal thread may be configured to threadingly engage with the external thread of the plunger rod tip 444 when the plunger rod 440 is coupled to the plunger tip 450. The plunger tip 450 also may include an inner rim 459 or protrusion disposed in the bore 457 opposite to the opening of the bore 457. The inner rim 459 may fit within the recess 460 of the plunger rod tip 444 such that at least a portion of the plunger rod tip 444 fits between the inner rim 459 and the internal wall including the internal thread 455 of the plunger tip 455 to form friction lock between the plunger tip 450 and the plunger rod tip 444.
Ribs 454 can extend distally from distally facing surfaces of the distal flange 452. The ribs 454 can be configured to engage with the seal member 170 to support the seal member 170 when the seal member 170 is under pressure. In some embodiments, the ribs 454 are aligned with the fins of the medial portion 456. For example, in the illustrated embodiment, the number of fins in the medial portion 456 and the number of ribs 454 on the distally facing surface of the distal flange 452 is four, with the fins of the medial portion 456 and the ribs 454 being generally aligned with one another. In other embodiments, the number of fins in the medial portion 456 and the number of ribs 454 on the distally facing surface of the distal flange 452 may be two, three, five, six, or more. In other embodiments, the fins of the medial portion 456 and the ribs 454 may be misaligned. In some embodiments, the ribs 454 may connect with one another at the axis or center point 461 of the plunger tip 450. The ribs 454 may angle or taper towards the distally facing surface of the distal flange 452 from the axis or center point 461 towards an outer periphery of the distal flange 452.
As shown, in
The seal member 170 may be formed from a polymeric material. In some embodiments, the seal member 170 may be formed from silicone or poly-siloxane. In some other embodiments, the seal member 170 may be formed from a silicone-free material or poly-siloxane-free material. For example, the seal member 170 may be formed from a thermoplastic elastomer, such as chlorobutyl rubber, bromobutyl rubber, or neoprene. Seal members 170 formed from other suitable materials are also within the scope of this disclosure.
In various embodiments, the proximal ridge 171, the medial ridge 173, and/or the distal ridge 172 may exert a radial force on an interior surface of a first wall 111 of the barrel 110, as shown in
In certain embodiments, the proximal ridge 171, the distal ridge 172, and/or the medial ridge 173 may be configured such that these ridges 171, 172, 173 are compressed within the barrel 110 to form a seal between an outer surface of the seal member 170 and the inner surface of the first wall 111 of the barrel 110. In some embodiments, the compressed portions of the seal member 170 may exert a radial outward force on the inner surface of the first wall 111 of the barrel 110 and may conform to the first wall 111 of the barrel 110. This sealing force may be configured to contain pressured fluids within the barrel and thus the seal member 170 may create a pressure seal when compressed within the barrel 110. In other words, in some embodiments, the proximal ridge 171, the distal ridge 172, and/or the medial ridge 173 may form a pressure seal against the inner surface of the first wall 111 of the barrel 110, analogous to an O-ring, for instance.
Kits comprising syringe systems or syringe bodies at least partially pre-loaded with an injectable material are disclosed herein. In some embodiments, the pre-loaded syringe system may comprise a barrel at least partially loaded with the injection material and a plunger in communication with an interior surface of the barrel. In some other embodiments, the pre-loaded syringe body may comprise a barrel at least partially loaded with the injection material. In certain embodiments, the injection material of the kit may be dry. In certain other embodiments, the injection material of the kit may be suspended in a liquid such as, but not limited to, a carrier liquid comprising saline.
In some embodiments, the kit and/or the components of the kit may be configured to be shelf stable for at least six months, for at least one year, for at least two years, for at least three years, or for another suitable period of time. In certain embodiments, the syringe system or syringe body of the kit may comprise sterilization compatible materials and/or irradiation compatible materials.
Methods of manufacture of the syringe system 100 are also disclosed herein.
In some embodiments, the methods may also comprise coupling the plunger tip 150 with the seal member 170 by inserting the distal flange 152 into the cavity 174 such that the distal flange 152 is disposed distally of the shoulder 175. The assembly of the plunger tip 150 and the seal member 170 can be inserted into the barrel 110 and positioned at or adjacent the non-lubricated portion 122 as shown in
In certain embodiments, the methods may also comprise applying the lubricant 114 on at least a portion of an interior surface of a portion of the first wall 111 of the barrel 110. As shown in
As depicted in
As illustrated in
As illustrated in
As illustrated in
In use, the injectable material container 300 may be utilized to hydrate the injectable material disposed within the chamber 393. A method of hydrating injectable material may comprise the steps of coupling a first fluid delivery device to the first port 391 of the injectable material container 300 and coupling a second fluid delivery device to the second port 392 of the injectable material container 300. The first and/or second fluid delivery device may comprise an injectable fluid (e.g., saline and/or contrast media). The injectable fluid from the first fluid delivery device can be injected through the first port 391, through the chamber 393, through the second port 392, and into the second fluid delivery device. When the injectable fluid passes through the chamber 393, the injectable material may be displaced by the injectable fluid into the second fluid delivery device. To ensure mixing and hydrating of the injectable material with the injectable fluid, the injectable fluid and injectable material can be repeatably displaced between the first and second fluid delivery devices through the chamber 393.
Any methods disclosed herein comprise one or more steps or actions for performing the described method. The method steps and/or actions may be interchanged with one another. In other words, unless a specific order of steps or actions is required for proper operation of the embodiment, the order and/or use of specific steps and/or actions may be modified. For example, a method of manufacture of a syringe system may include one or more of the following steps: filling a distal reservoir portion of a syringe barrel with injectable particles; positioning a seal member within the syringe barrel, wherein a distal reservoir portion of the syringe barrel is disposed distal of the seal member and a proximal reservoir portion of the syringe barrel is disposed proximal of the seal member; applying a lubricant to an internal surface of the proximal reservoir portion; and coupling a syringe plunger to the seal member, wherein the syringe plunger comprises: a plunger rod; and a plunger tip disposed at a distal end of the plunger rod. Other steps are also contemplated.
Reference throughout this specification to “an embodiment” or “the embodiment” means that a particular feature, structure, or characteristic described in connection with that embodiment is included in at least one embodiment. Thus, the quoted phrases, or variations thereof, as recited throughout this specification are not necessarily all referring to the same embodiment.
Similarly, in the above description of embodiments, various features are sometimes grouped together in a single embodiment, figure, or description thereof for the purpose of streamlining the disclosure. This method of disclosure, however, is not to be interpreted as reflecting an intention that any claim requires more features than those expressly recited in that claim. Rather, as the following claims reflect, inventive aspects lie in a combination of fewer than all features of any single foregoing disclosed embodiment.
“Fluid” is used in its broadest sense, to refer to any fluid, including both liquids and gases as well as solutions, compounds, suspensions, etc., which generally behave as fluids.
The phrases “connected to,” “coupled to,” and “in communication with” refer to any form of interaction between two or more entities, including but not limited to mechanical, electrical, magnetic, electromagnetic, fluid, and thermal interaction. Two components may be coupled to each other even though they are not in direct contact with each other. For example, two components may be coupled to each other through an intermediate component.
The terms “proximal” and “distal” refer to opposite ends of a medical device, including the devices disclosed herein. As used herein, the proximal portion of a medical device is the portion nearest a practitioner during use, while the distal portion is the portion at the opposite end. For example, the proximal end of a syringe system is defined as the end closest to the practitioner during utilization of the syringe system. The distal end is the end opposite the proximal end, along the longitudinal direction of the syringe system.
References to approximations are made throughout this specification, such as by use of the term “substantially.” For each such reference, it is to be understood that, in some embodiments, the value, feature, or characteristic may be specified without approximation. For example, where qualifiers such as “about” and “substantially” are used, these terms include within their scope the qualified words in the absence of their qualifiers. For example, where the term “substantially perpendicular” is recited with respect to a feature, it is understood that in further embodiments, the feature can have a precisely perpendicular configuration.
The terms “a” and “an” can be described as one, but not limited to one. For example, although the disclosure may recite a housing having “a stopper,” the disclosure also contemplates that the housing can have two or more stoppers.
Unless otherwise stated, all ranges include both endpoints and all numbers between the endpoints.
Recitation in the claims of the term “first” with respect to a feature or element does not necessarily imply the existence of a second or additional such feature or element.
The claims following this written disclosure are hereby expressly incorporated into the present written disclosure, with each claim standing on its own as a separate embodiment. This disclosure includes all permutations of the independent claims with their dependent claims. Moreover, additional embodiments capable of derivation from the independent and dependent claims that follow are also expressly incorporated into the present written description.
Without further elaboration, it is believed that one skilled in the art can use the preceding description to utilize the invention to its fullest extent. The claims and embodiments disclosed herein are to be construed as merely illustrative and exemplary, and not a limitation of the scope of the present disclosure in any way. It will be apparent to those having ordinary skill in the art, with the aid of the present disclosure, that changes may be made to the details of the above-described embodiments without departing from the underlying principles of the disclosure herein. In other words, various modifications and improvements of the embodiments specifically disclosed in the description above are within the scope of the appended claims. Moreover, the order of the steps or actions of the methods disclosed herein may be changed by those skilled in the art without departing from the scope of the present disclosure. In other words, unless a specific order of steps or actions is required for proper operation of the embodiment, the order or use of specific steps or actions may be modified. The scope of the invention is therefore defined by the following claims and their equivalents.
This application claims priority to U.S. Provisional Application No. 63/380,893, filed on Oct. 25, 2022 and titled, “Injectable Material Hydrating Devices and Related Methods” and U.S. Provisional Application No. 63/486,598, filed on Feb. 23, 2023 and titled, “Injectable Material Hydrating Devices and Related Methods,” both of which are hereby incorporated by reference in their entireties.
Number | Date | Country | |
---|---|---|---|
63380893 | Oct 2022 | US | |
63486598 | Feb 2023 | US |